13FPAULSON & CO. INC.
Reported value
$2.6B-17.2 % vs prior
Positions
8-1 vs prior
Top-10 concentration
100 %
of latest filing
New / Exit
1 / 2
vs prior quarter
Last filed
Aug 14, 2026
period Q2 2026
Reported value by quarter
Top holdings
Holdings — Q2 2026
Sorted by size. Change vs prior filing (Q1 2026) .
| Change | Ticker | Issuer | Weight | Prev | Δ | Value | Shares |
|---|---|---|---|---|---|---|---|
| ADD | MDGL | MADRIGAL PHARMACEUTICALS INC | 27.9 % | 23.4 % | +4.5 pp | $719.5M | 1,340,020 |
| TRIM | PPTA | PERPETUA RESOURCES CORP | 26.1 % | 29.2 % | -3.2 pp | $671.5M | 32,347,299 |
| ADD | AAMI | ACADIAN ASSET MANAGEMENT INC | 16.2 % | 13.5 % | +2.7 pp | $417.9M | 5,843,282 |
| ADD | BHC | BAUSCH HEALTH COS INC | 14.0 % | 12.7 % | +1.3 pp | $361.2M | 73,255,869 |
| ADD | THM | INTERNATIONAL TOWER HILL MIN | 8.1 % | 7.4 % | +0.7 pp | $207.9M | 104,486,703 |
| TRIM | NG | NOVAGOLD RESOURCES INC | 6.3 % | 7.9 % | -1.5 pp | $162.6M | 27,238,061 |
| EXIT | AEM | AGNICO EAGLE MINES LTD | — | 5.1 % | -5.1 % | — | — |
| ADD | THRY | THRYV HLDGS INC | 1.3 % | 0.7 % | +0.5 pp | $33.3M | 8,443,835 |
| NEW | GOOGL | ALPHABET INC | 0.1 % | — | NEW | $1.8M | 5,000 |
| EXIT | AM6 | AMICUS THERAPEUTIC | — | 0.0 % | -0.0 % | — | — |
Filing history
| Quarter | Reported value | Positions | Filed | Form |
|---|---|---|---|---|
| Q2 2026 | $2.6B | 8 | 2026-08-14 | 13F-HR |
| Q1 2026 | $3.1B | 9 | 2026-05-15 | 13F-HR |
| Q4 2025 | $3.3B | 9 | 2026-02-17 | 13F-HR |
| Q3 2025 | $3.0B | 10 | 2025-11-14 | 13F-HR |
| Q2 2025 | $2.0B | 15 | 2025-08-14 | 13F-HR |
| Q1 2025 | $1.7B | 14 | 2025-05-15 | 13F-HR |
| Q4 2024 | $1.7B | 13 | 2025-02-14 | 13F-HR |
| Q3 2024 | $1.4B | 15 | 2024-11-14 | 13F-HR |
| Q2 2024 | $1.4B | 16 | 2024-08-14 | 13F-HR |
| Q3 2023 | $1.1B | 18 | 2023-11-14 | 13F-HR |
| Q2 2023 | $1.0B | 21 | 2023-08-14 | 13F-HR |
| Q1 2023 | $1.2B | 20 | 2023-05-15 | 13F-HR |
| Q4 2022 | $1.1B | 22 | 2023-02-14 | 13F-HR |
| Q3 2022 | $1.4B | 28 | 2022-11-14 | 13F-HR |
| Q2 2022 | $2.0B | 32 | 2022-08-15 | 13F-HR |
| Q1 2022 | $3.2B | 33 | 2022-05-16 | 13F-HR |
| Q4 2021 | $3.2B | 36 | 2022-02-14 | 13F-HR |
| Q3 2021 | $3.5B | 37 | 2021-11-15 | 13F-HR |
| Q2 2021 | $4.2B | 39 | 2021-08-16 | 13F-HR |
| Q1 2021 | $4.4B | 35 | 2021-05-17 | 13F-HR |
| Q4 2020 | $3.8B | 35 | 2021-02-16 | 13F-HR |
| Q3 2020 | $3.2B | 31 | 2020-11-16 | 13F-HR |
| Q2 2020 | $3.1B | 30 | 2020-08-14 | 13F-HR |
| Q1 2020 | $2.6B | 33 | 2020-05-15 | 13F-HR |
| Q4 2019 | $4.6B | 37 | 2020-02-14 | 13F-HR |
| Q3 2019 | $4.9B | 44 | 2019-11-14 | 13F-HR |
| Q2 2019 | $5.6B | 49 | 2019-08-14 | 13F-HR |
| Q1 2019 | $4.7B | 50 | 2019-08-14 | 13F-HR/A |
| Q1 2019 | $4.5B | 49 | 2019-05-15 | 13F-HR |
| Q4 2018 | $4.2B | 51 | 2019-02-14 | 13F-HR |
| Q3 2018 | $5.3B | 52 | 2018-11-14 | 13F-HR |
| Q2 2018 | $4.9B | 51 | 2018-08-14 | 13F-HR |
| Q1 2018 | $4.6B | 50 | 2018-05-15 | 13F-HR |
| Q4 2017 | $5.1B | 54 | 2018-02-14 | 13F-HR |
| Q3 2017 | $5.6B | 54 | 2017-11-14 | 13F-HR |
| Q2 2017 | $7.3B | 103 | 2017-09-20 | 13F-HR/A |
| Q2 2017 | $7.3B | 103 | 2017-08-14 | 13F-HR |
| Q1 2017 | $7.5B | 91 | 2017-05-15 | 13F-HR |
| Q4 2016 | $7.7B | 91 | 2017-02-14 | 13F-HR |
| Q3 2016 | $9.1B | 90 | 2016-11-14 | 13F-HR |
| Q2 2016 | $9.7B | 81 | 2016-08-15 | 13F-HR |
| Q1 2016 | $13.4B | 88 | 2016-05-16 | 13F-HR |
| Q4 2015 | $16.7B | 77 | 2016-02-16 | 13F-HR |
| Q3 2015 | $19.3B | 65 | 2015-11-16 | 13F-HR |
| Q2 2015 | $21.7B | 61 | 2015-08-14 | 13F-HR |
| Q1 2015 | $19.6B | 61 | 2015-05-15 | 13F-HR |
| Q4 2014 | $19.4B | 63 | 2015-02-17 | 13F-HR |
| Q3 2014 | $24.1B | 75 | 2014-11-14 | 13F-HR |
| Q2 2014 | $23.1B | 82 | 2014-08-14 | 13F-HR |
| Q1 2014 | $20.4B | 80 | 2014-05-15 | 13F-HR |
| Q4 2013 | $20.3B | 87 | 2014-02-14 | 13F-HR |
| Q3 2013 | $15.5B | 87 | 2013-11-14 | 13F-HR |
| Q2 2013 | $14.2B | 91 | 2013-08-14 | 13F-HR |
Reported as of quarter end, filed up to ~45 days later, not live positions. Values are as reported in the filing (not marked to today’s prices).